. Author manuscript; available in PMC: 2010 May 1.

Published in final edited form as: Pharmacogenomics. 2009 Jul;10(7):1139–1146. doi: 10.2217/pgs.09.35

Table 2. Allele and genotype frequencies for haplotype marker in the candidate genes in 85 cancer patients.

Gene	Polymorphism	dbSNP ID	Allele 1 (frequency)	Allele 2 (frequency)	Genotype, no. of patients (frequency)
Gene	Polymorphism	dbSNP ID	Allele 1 (frequency)	Allele 2 (frequency)	1/1	1/2	2/2
PARP1	c.852 (A284A)	rs1805414	T (0.62)	C (0.38)	35 (0.41)	35 (0.41)	15 (0.18)
PARP1	IVS19-297	rs3219142	C (0.81)	T (0.19)	59 (0.69)	19 (0.22)	7 (0.08)
TDP1	IVS12+79	rs2401863	T (0.64)	G (0.36)	37 (0.44)	35 (0.41)	13 (0.15)
TOP1	IVS4+61	rs6072262	G (0.88)	A (0.12)	67 (0.79)	15 (0.18)	3 (0.04)
XRCC1	-1449delGGCC	rs3213239	GGCC (0.58)	del (0.42)	29 (0.34)	41 (0.48)	15 (0.18)
XRCC1	c.1196 (R399Q)	rs25487	G (0.74)	A (0.26)	47 (0.55)	32 (0.38)	6 (0.07)